Client of a consultant lobbyist
Medical Technology Association of Canada (Medtech Canada)
- Meetings this Parliament
- 10
- With MPs
- 0
- Since Nov 2021
- 23
- Active registrations
- 1
Most recent reported meeting: Sep 28, 2026.
Lobbying by Medical Technology Association of Canada (Medtech Canada): its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.
← LobbyingRegistrations in effect
Consultant In effect since Jul 31, 2025
Consultant Sandra Leffler of Leffler Consulting
Consultant lobbyists
-
Sandra Leffler
Former public office holder
Formerly Special Assistant to the Minister of Industry, Minister's Office, Industry Canada (2001–2003)
Formerly Special Assistant to the Minister of Health, Minister's Office, Health Canada (1997–2001)
Institutions they may lobby: Atlantic Canada Opportunities Agency (ACOA), CUSMA Secretariat, Canada Border Services Agency (CBSA), Canada Foundation for Innovation, Canadian Intergovernmental Conference Secretariat, Environment and Climate Change Canada (ECCC), Export Development Canada (EDC), Finance Canada (FIN), Global Affairs Canada (GAC), Health Canada (HC), House of Commons, Innovation, Science and Economic Development Canada (ISED), Intergovernmental Affairs Secretariat (IGA), Prime Minister's Office (PMO), Public Services and Procurement Canada (PSPC), Senate of Canada
What they're lobbying on (7)Hide details
- Communicate with government on behalf of members, regarding the impact of changes to Canada-US Trade agreements, as they apply to medical technologies.
- Following Royal Assent of Bill C-244, An Act to Amend the Copyright Act (diagnosis, maintenance and repair), monitor development of a right to repair framework and its potential impact on the medical device industry. Communicate with government potential regulatory measures to protect patient safety as a consequence of Bill C-244 and future policies and/org legislation regarding right to repair.
- Establishment of a Diabetes Fund for medical devices associated with diabetes management.
- Monitor and participate in discussions to advance and support digital health and data.
- Medical Device Regulations (SOR/98-282) that require compliance by the medical device technology industry. Addressing issues and providing advice related to Medical Device Regulations in Canada
- Development of policies that will improve the market in Canada for innovative medical technologies.
- C-244 An Act to amend the Copyright Act (Diagnosis, Maintenance and Repair Gain information on the potential impacts for the medical device industry and given any patient safety concerns, seek relevant amendments.
Registration 779048-372637-8. Look it up in the official Registry
Reported meetings
Spreadsheet-
Reported by Sandra Leffler · Consultant
- Carlos Vanderloo · Minister (Econonmic), Global Affairs Canada (GAC)
- Tanya Allem · Minister-Counsellor (Trade Policy), Global Affairs Canada (GAC)
- kaitlyn Pritchard · Trade Program Manager, Innovation & Industrial Policy, Global Affairs Canada (GAC)
Communicate with government on behalf of members, regarding the impact of changes to Canada-US Trade agreements, as they apply to medical technologies.
-
Reported by Sandra Leffler · Consultant
- kaitlyn Pritchard · Trade Program Manager, Innovation and Industrial Policy, Global Affairs Canada (GAC)
Communicate with government on behalf of members, regarding the impact of changes to Canada-US Trade agreements, as they apply to medical technologies.
-
Reported by Sandra Leffler · Consultant
- Rodrigo Arancibia · Acting Director General, Innovation, Science and Economic Development Canada (ISED)
Communicate with government on behalf of members, regarding the impact of changes to Canada-US Trade agreements, as they apply to medical technologies. Read more
Development of policies that will improve the market in Canada for innovative medical technologies.
-
Reported by Sandra Leffler · Consultant
- David McFarlane · Director of Policy, Innovation, Science and Economic Development Canada (ISED)
- Manuela Tomic · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Development of policies that will improve the market in Canada for innovative medical technologies. Read more
Communicate with government on behalf of members, regarding the impact of changes to Canada-US Trade agreements, as they apply to medical technologies.
-
Reported by Sandra Leffler · Consultant
- Rodrigo Arancibia · Acting Director General, Innovation, Science and Economic Development Canada (ISED)
Development of policies that will improve the market in Canada for innovative medical technologies.
-
Reported by Sandra Leffler · Consultant
- Rodrigo Arancibia · Acting Director General, Innovation, Science and Economic Development Canada (ISED)
- Ritu Banerjee · Interim Head, Innovation, Science and Economic Development Canada (ISED)
Communicate with government on behalf of members, regarding the impact of changes to Canada-US Trade agreements, as they apply to medical technologies. Read more
Development of policies that will improve the market in Canada for innovative medical technologies.
-
Reported by Sandra Leffler · Consultant
- Niloo Boroun · Director of International Policy, Finance Canada (FIN)
Communicate with government on behalf of members, regarding the impact of changes to Canada-US Trade agreements, as they apply to medical technologies.
-
Reported by Sandra Leffler · Consultant
- Rodrigo Arancibia · Acting Director General, Innovation, Science and Economic Development Canada (ISED)
Communicate with government on behalf of members, regarding the impact of changes to Canada-US Trade agreements, as they apply to medical technologies. Read more
Development of policies that will improve the market in Canada for innovative medical technologies.
Monitor and participate in discussions to advance and support digital health and data.
-
Reported by Sandra Leffler · Consultant
- Galen Richardson · Senior Advisor Stakeholder Relations, Intergovernmental Affairs Secretariat (IGA)
Communicate with government on behalf of members, importance of Canada-US Trade agreements as they apply to medical technologies.
-
Reported by Sandra Leffler · Consultant
- Jade Mallette · Chief of Staff, Health Canada (HC)
- Sandenga Yeba · Senior Policy Advisor, Health Canada (HC)
Communicate with government on behalf of members, importance of Canada-US Trade agreements as they apply to medical technologies.
-
Reported by Sandra Leffler · Consultant
- Rodrigo Arancibia · Acting Director General, Innovation, Science and Economic Development Canada (ISED)
Development of policies that will improve the market in Canada for innovative medical technologies. Read more
Communicate with government on behalf of members, importance of Canada-US Trade agreements as they apply to medical technologies.
-
Reported by Sandra Leffler · Consultant
- Eshan Naik · Deputy Chief of Staff and Director of Policy, Health Canada (HC)
Communicate with government on behalf of members, importance of Canada-US Trade agreements as they apply to medical technologies.
-
Reported by Sandra Leffler · Consultant
- Rodrigo Arancibia · Acting Director General, Innovation, Science and Economic Development Canada (ISED)
Following Royal Assent of Bill C-244, An Act to Amend the Copyright Act (diagnosis, maintenance and repair), monitor development of a right to repair framework and its potential impact on the medical device industry. Communicate with government potential regulatory measures to protect patient safety as a consequence of Bill C-244 and future policies and/org legislation regarding right to repair. Read more
-
Reported by Sandra Leffler · Consultant
- Jason Easton · Strategic Advisor Special Projects, Prime Minister's Office (PMO)
Communicate with government on behalf of members, importance of Canada-US Trade agreements as they apply to medical technologies.
-
Reported by Sandra Leffler · Consultant
- Jonathan Alomoto · Senior Policy Advisor, Global Affairs Canada (GAC)
Communicate with government on behalf of members, importance of Canada-US Trade agreements as they apply to medical technologies.
-
Reported by Sandra Leffler · Consultant
- Jason Easton · Strategic Advisor Special Projects, Prime Minister's Office (PMO)
Communicate with government on behalf of members, importance of Canada-US Trade agreements as they apply to medical technologies.
-
Reported by Sandra Leffler · Consultant
- Jonathan Alomoto · Senior Policy Advisor, Global Affairs Canada (GAC)
Communicate with government on behalf of members, importance of Canada-US Trade agreements as they apply to medical technologies.
-
Reported by Sandra Leffler · Consultant
- benoit leduc · Manager, Innovation, Science and Economic Development Canada (ISED)
- Rodrigo Arancibia · Acting Director General, Innovation, Science and Economic Development Canada (ISED)
Following Royal Assent of Bill C-244, An Act to Amend the Copyright Act (diagnosis, maintenance and repair), monitor development of a right to repair framework and its potential impact on the medical device industry. Communicate with government potential regulatory measures to protect patient safety as a consequence of Bill C-244 and future policies and/org legislation regarding right to repair. Read more
-
Reported by Sandra Leffler · Consultant
- Jade Mallette · Director of Parliamentary Affairs, Health Canada (HC)
Federal-Provincial RelationsHealthScience and Technology
-
Reported by Sandra Leffler · Consultant
- Lucie Masciello · Director, Health Canada (HC)
- Sally Prawdzik · Acting Director, Health Canada (HC)
- Matthew Ryan · Manager, Health Canada (HC)
- Bruce Randall · Acting Director General, Health Canada (HC)
HealthIndustry
-
Reported by Sandra Leffler · Consultant
- Mark Schaan · Senior Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
- Patrick Blanar · Director, Innovation, Science and Economic Development Canada (ISED)
- Samir Chhabra · Director General, Innovation, Science and Economic Development Canada (ISED)
HealthIndustry
-
Reported by Sandra Leffler · Consultant
- Colin Deacon · Senator, Senate of Canada
- Benedicta Arthur · Parliamentary Affairs Advisor, Senate of Canada
- David Diab · Policy Advisor, Senate of Canada
Health
-
Reported by Sandra Leffler · Consultant
- Sandenga Yeba · Senior Policy Advisor, Health Canada (HC)
Health
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.